The global drug testing market size is estimated to reach USD 18.62 billion by 2030, registering to grow at a CAGR of 5.1% from 2025 to 2030 according to a new report by Grand View Research, Inc. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.
Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.
For instance, in June 2019, Quidel Corporation received the U.S. FDA’s 510(k) clearance to market its fluorescence immunoassay-Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.
Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.
Request a free sample copy or view report summary: Drug Testing Market Report
The consumables segment captured the largest revenue share of 34.6% in 2024. Consumables are vital for testing and encompass a variety of items, including reagents, columns, kits, calibrators, specimens, blue dye tablets, temperature test strips, and controls.
Urine samples segment accounted for the largest share of 77.7% in 2024, primarily due to their widespread acceptance and reliability.
The cannabis/marijuana segment dominated the market in 2024. The segment accounted for 57.5% of the overall market. This can be attributed to the increasing use of marijuana or cannabis as an illicit drug in the world, creating a demand for its kits and instruments.
The drug testing laboratories segment dominated the market in 2024. This can be attributed to drug testing laboratories' large presence and offerings. Advantages of these laboratories include the availability of sophisticated equipment, such as High-Performance Liquid Chromatography (HPLC) & spectroscopy, and trained personnel for conducting tests for effective results.
Grand View Research has segmented the global drug testing market based on product, sample, drug, end-use, and region:
Drug Testing Product Outlook (Revenue, USD Million, 2018 - 2030)
Consumables
Instruments
Rapid Testing Devices
Services
Drug Testing Sample Outlook (Revenue, USD Million, 2018 - 2030)
Urine Samples
Oral Fluid Samples
Hair Samples
Other Samples
Drug Testing Drug Outlook (Revenue, USD Million, 2018 - 2030)
Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others
Drug Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)
Drug Testing Laboratories
Workplaces
Hospitals
Others
Drug Testing Regional Outlook (Revenue in USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Russia
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in the Drug Testing Market
Quest Diagnostics Incorporated
Abbott
F. Hoffmann-La Roche Ltd.
Quidel Corporation
Thermo Fisher Scientific, Inc.
Siemens Healthcare GmbH
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Laboratory Corporation of America Holdings
Clinical Reference Laboratory, Inc.
Cordant Health Solutions
"The quality of research they have done for us has been excellent..."